BCL2L11 and central nervous system cancer: To further delineate the key role of SPHK1 in triggering the activation of Akt/FOXO3a/Bim signaling cascade, the kinase activity of SPHK1 was suppressed by SPHK1 inhibitor (SK-I) in SPHK1-overexpressing glioma cells.